Top Growth Trends in the Nucleic Acid Amplification Testing Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the nucleic acid amplification testing market grown in recent years?
The nucleic acid amplification testing market has experienced significant growth, projected to expand from $9.56 billion in 2024 to $11.03 billion in 2025 at a CAGR of 15.3%. Key drivers of historical growth include increasing awareness of infectious disease diagnosis, the emergence of new pathogens, the shift towards personalized medicine, demand for point-of-care testing, and regulatory approvals.
How is the nucleic acid amplification testing market size expected to evolve during the forecast period?
The nucleic acid amplification testing market is set for rapid expansion, projected to reach $19.26 billion by 2029 at a CAGR of 15.0%. Growth drivers include the rising prevalence of infectious diseases, the need for large-scale testing, increased private sector investments, demand for fast and precise diagnostics, and advancements in testing technologies. Key trends include AI integration, development of wearable and implantable diagnostic devices, increased adoption in point-of-care testing, expansion in personalized medicine, and integration with digital health platforms.
Get your nucleic acid amplification testing market report here!
Which key drivers are propelling the nucleic acid amplification testing market’s growth?
The rising incidence of infectious diseases is expected to accelerate the growth of the nucleic acid amplification testing market. Infectious diseases are spreading due to antibiotic resistance, climate change, and changes in human behavior. Nucleic acid amplification testing (NAAT) enables rapid and accurate detection of pathogens, ensuring timely treatment and helping control disease spread. In the 2022-2023 season, there were 4,216 hospitalizations related to influenza in Canada. This rising incidence of infectious diseases is fueling the nucleic acid amplification testing market.
What are the market segments in the nucleic acid amplification testing industry?
The nucleic acid amplification testingmarket covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp
Which leading companies are shaping the growth of the nucleic acid amplification testing market?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation
What key trends are currently impacting the nucleic acid amplification testing market’s development?
Leading firms in the nucleic acid amplification testing market are concentrating on creating novel solutions like in vitro diagnostics (IVD) assays. These are designed to screen donated blood for CMV using nucleic acid amplification technology (NAT) in compliance with IVDR. IVD assays are lab-based tests conducted on biological samples to identify diseases, conditions or infections. For example, GFE, a company based in Germany, launched PoET CMV in June 2024. This IVD assay is meant for fast and accurate detection of cytomegalovirus (CMV) infections. It boasts of high sensitivity and specificity which makes early diagnosis and effective monitoring of CMV possible in transplant patients and people with compromised immunity. The assay employs sophisticated molecular techniques to provide trustworthy results promptly, thereby aiding in prompt clinical decision-making.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19619
Which geographic areas are influencing the growth of the nucleic acid amplification testing market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024
Nucleic Acid Isolation & Purification Global Market Report 2024
Nucleic Acid Based Gene Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
